
A resurgence in this IOL technology could create new possibilities in refractive correction

A resurgence in this IOL technology could create new possibilities in refractive correction


The first human clinical trial to preliminarily evaluate the safety and efficacy of cellular therapy with mesenchymal stem cells for the corneal stroma has shown promise.

Published: January 8th 2018 | Updated:

Published: September 4th 2018 | Updated: